Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli.
Mathias, R G
Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli. [electronic resource] - The Journal of infectious diseases Nov 1976 - S394-401 p. digital
Publication Type: Journal Article
0022-1899
10.1093/infdis/135.supplement_2.s394 doi
Adolescent
Adult
Aged
Amikacin--adverse effects
Aminoglycosides--pharmacology
Bacterial Infections--drug therapy
Enterobacteriaceae Infections--drug therapy
Humans
Kanamycin--analogs & derivatives
Microbial Sensitivity Tests
Middle Aged
Pseudomonas Infections--drug therapy
Pseudomonas aeruginosa--drug effects
Sepsis--drug therapy
Urinary Tract Infections--drug therapy
Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli. [electronic resource] - The Journal of infectious diseases Nov 1976 - S394-401 p. digital
Publication Type: Journal Article
0022-1899
10.1093/infdis/135.supplement_2.s394 doi
Adolescent
Adult
Aged
Amikacin--adverse effects
Aminoglycosides--pharmacology
Bacterial Infections--drug therapy
Enterobacteriaceae Infections--drug therapy
Humans
Kanamycin--analogs & derivatives
Microbial Sensitivity Tests
Middle Aged
Pseudomonas Infections--drug therapy
Pseudomonas aeruginosa--drug effects
Sepsis--drug therapy
Urinary Tract Infections--drug therapy